Q-NMN
Nicotinamide Mononucleotide
NMN is a key precursor to NAD⁺ — the molecule that powers cellular energy, mitochondrial function, and healthy aging. Through advanced PQNS delivery technology, NMN achieves enhanced bioavailability and optimized systemic performance.
"Cellular energy. Metabolic support. Sustained vitality."
Precursor
CAGR to 2030
Delivery Platform
Size by 2030
What is NMN?
The Cellular Energy
Molecule
Nicotinamide Mononucleotide (NMN) is a nucleotide derivative and a direct biosynthetic precursor to Nicotinamide Adenine Dinucleotide (NAD⁺)—a critical coenzyme involved in cellular energy metabolism, mitochondrial function, DNA repair, and sirtuin activation.
NMN in Human Health
Mechanisms & Benefits
By elevating NAD⁺ levels, NMN activates foundational cellular processes that decline with age — restoring energy, protecting DNA, and supporting systemic wellness across multiple pathways.
- Support healthy insulin sensitivity
- Improve vascular function
- Enhance lipid metabolism
- DNA repair via PARP activation
- Neuroprotection and cognitive support pathways
- Sirtuin activation linked to longevity
NMN Market Landscape
A Market Experiencing
Exponential Growth
The global NMN nutraceutical market is experiencing exponential growth, driven by an aging population and rising interest in longevity and wellness.
The global NMN market was valued at US$253 million in 2020 and is projected to grow to roughly US$762 million by 2030, reflecting a compound annual growth rate (CAGR) of approximately 10.9%.
- Aging population
- Rising interest in longevity and wellness
Brands worldwide are launching NMN-based supplements in capsule, sachet, tablet, and liquid forms.
Challenges in Conventional NMN Products
Critical Limitations of
Traditional Formulations
Despite strong demand, traditional NMN formulations face critical limitations that reduce their clinical effectiveness and value to consumers.
- NMN is water-soluble but susceptible to degradation in the gastrointestinal (GI) tract
- Rapidly metabolized before systemic uptake
- Limited transport across intestinal epithelial membranes
- Oral NMN absorption can be inconsistent, leading to interpersonal variability in response
- Reduced clinical effect despite high "label claim" dosage
- NMN can degrade in high heat and high humidity
- Instability in acidic environments
- This can reduce shelf life and product efficacy
How PQNS Elevates NMN Performance
Mechanistic Advantages
of PQNS-NMN
PQNS (Phospholipid-based Quantum Nano System) is a cutting-edge delivery technology engineered to address the core limitations of conventional and liposomal NMN formulations.
Benefits of PQNS-NMN over Conventional and Liposomal Formulations
PQNS-NMN vs Conventional
vs Liposomal
A comprehensive comparison of delivery technologies demonstrates the clear mechanistic advantages of the PQNS cationic phospholipid nano system for hydrophilic bioactives like NMN.
| Parameter | Conventional NMN Capsule | Liposomal NMN | PQNS-NMN (Cationic Phospholipid Nano System) |
|---|---|---|---|
| Core Limitation of NMN | Hydrophilic; membrane permeability limited; enzymatic exposure | Same intrinsic NMN limitations | Engineered to address permeability and stability challenges |
| GI Protection | Direct exposure to gastric acid and enzymes | Partial vesicular protection | Designed to enhance protection via nano-encapsulation |
| Mucosal Interaction | Minimal electrostatic interaction | Limited interaction | Increased electrostatic interaction with negatively charged intestinal mucosa |
| Membrane Uptake | Transporter-dependent | Fusion or passive uptake | Enhanced membrane affinity due to cationic surface (mechanistically favorable for uptake) |
| Absorption Consistency | Variable | Case-dependent improvement | Designed to improve intestinal interaction and absorption potential |
| Dispersion Stability | Not applicable | Vesicle fusion possible | Electrostatic repulsion may improve colloidal stability |
| Dose Utilization | Higher doses commonly used | May improve utilization | Lower dosage required |
| Technology Positioning | Commodity format | Established platform | Charge-engineered nano platform suited for hydrophilic bioactives like NMN |
PQNS Delivery Technology
What is PQNS?
PQNS (Phospholipid-based Quantum Nano System) is a cutting-edge delivery technology that encapsulates NMN in nano-sized phospholipid carriers to maximize bioavailability, stability, and systemic efficacy.
Regulatory & Quality Advantages
Premium Positioning
Through Science
PQNS-NMN delivers not only superior clinical performance but also distinct commercial and regulatory advantages that enable brands to build differentiated, science-backed products.
Advanced Cellular Energy Through
Precision Delivery Science.
NMN is a key precursor to NAD⁺ — the molecule that powers cellular energy, mitochondrial function, and healthy aging. Through advanced phospholipid-based nano delivery (PQNS), NMN achieves enhanced bioavailability, improved protection, and optimized systemic performance.
Contact Nutrition Formulators
